MA42175A1 - Pyrazolopyrimidine Derivatives as Btk Inhibitors for Cancer Treatment - Google Patents
Pyrazolopyrimidine Derivatives as Btk Inhibitors for Cancer TreatmentInfo
- Publication number
- MA42175A1 MA42175A1 MA42175A MA42175A MA42175A1 MA 42175 A1 MA42175 A1 MA 42175A1 MA 42175 A MA42175 A MA 42175A MA 42175 A MA42175 A MA 42175A MA 42175 A1 MA42175 A1 MA 42175A1
- Authority
- MA
- Morocco
- Prior art keywords
- cancer treatment
- btk inhibitors
- compounds
- pyrazolopyrimidine derivatives
- tyrosine kinase
- Prior art date
Links
Abstract
La présente invention concerne de nouveaux composés. Les composés selon l'invention sont des inhibiteurs de tyrosine kinase. Plus particulièrement, les composés selon l'invention sont utiles comme inhibiteurs de la tyrosine kinase de bruton (btk). L'invention concerne également l'utilisation de ces composés pour traiter des états pathologiques qui peuvent être traités par l'inhibition de la tyrosine kinase de bruton, par exemple le cancer, des lymphomes, la leucémie et des maladies immunologiques.The present invention relates to novel compounds. The compounds according to the invention are tyrosine kinase inhibitors. More particularly, the compounds of the invention are useful as inhibitors of the crude tyrosine kinase (btk). The invention also relates to the use of these compounds for treating pathological conditions that can be treated by the inhibition of broncine tyrosine kinase, for example cancer, lymphomas, leukemia and immunological diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1516445.2A GB201516445D0 (en) | 2015-09-16 | 2015-09-16 | Compounds |
PCT/GB2016/052897 WO2017046604A1 (en) | 2015-09-16 | 2016-09-16 | Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
MA42175A1 true MA42175A1 (en) | 2018-11-30 |
MA42175B1 MA42175B1 (en) | 2021-06-30 |
Family
ID=54363286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42175A MA42175B1 (en) | 2015-09-16 | 2016-09-16 | Pyrazolopyrimidine derivatives as btk inhibitors for cancer treatment |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201516445D0 (en) |
MA (1) | MA42175B1 (en) |
-
2015
- 2015-09-16 GB GBGB1516445.2A patent/GB201516445D0/en not_active Ceased
-
2016
- 2016-09-16 MA MA42175A patent/MA42175B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA42175B1 (en) | 2021-06-30 |
GB201516445D0 (en) | 2015-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA49809A1 (en) | Compounds used as kinase inhibitors | |
MX2018003351A (en) | Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer. | |
EA202092590A1 (en) | PYRIDAZINONES AS PARP7 INHIBITORS | |
EA202091709A1 (en) | DNA PC INHIBITORS | |
CY1108927T1 (en) | MITOTIC KINESIN SUSPENSIONS | |
DE60329756D1 (en) | MITOTIC KINESINE HEMMER | |
DE60231439D1 (en) | MITOTIC KINESINE HEMMER | |
DE60234278D1 (en) | MITOTIC KINESINE HEMMER | |
DE60329990D1 (en) | MITOTIC KINESINE HEMMER | |
ATE372341T1 (en) | INHIBITORS OF MITOTIC KINESIN | |
EP2170337A4 (en) | Novel triazolopyridazines | |
EA202091708A1 (en) | DNA PC INHIBITORS | |
MX2021006619A (en) | Tyrosine kinase inhibitors, compositions and methods there of. | |
PH12021550743A1 (en) | Boron containing pde4 inhibitors | |
MX2023001296A (en) | Compositions and methods for treating diseases and disorders. | |
NO20070589L (en) | Mitotic kinesin inhibitors. | |
MA42988B1 (en) | Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxamide | |
EA201890769A1 (en) | 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES | |
MA42175A1 (en) | Pyrazolopyrimidine Derivatives as Btk Inhibitors for Cancer Treatment | |
MA42871A1 (en) | Compounds used as inhibitors of crude tyrosine kinase (btk) | |
ATE426605T1 (en) | INHIBITORS OF MITOTIC KINESIN | |
EA202190902A1 (en) | FATTY ACID SYNTHASE INHIBITION (FASN) | |
MA51297B1 (en) | Quinazolinones as parp14 inhibitors | |
MA45367B1 (en) | Tyrosine kinase inhibitors | |
EA202190690A1 (en) | Boron-containing PDE4 inhibitors |